Iranian Company Produces Pressure Infusion Bag to Accelerate Blood Transfusion
“The blood pressure infusion bag is one of the products of our company that speeds up blood transfusion. This device is completely digital. It has a special cuff called pressure infusion cuff, which is connected to the device by connecting tubes,” Massoud Soroush, the production manager of a knowledge-based company, told ANA.
Noting that the device is used for trauma patients who have lost a lot of blood, he said, “The blood is injected into the patient’s bosy with very high pressure, and it is also used for patients who need cardiopulmonary resuscitation.”
“In the past, blood bags were injected into the patient with large syringes and with very high pressure, but in that situation, red blood cells were injected into the patient's body with extreme pressure, and the so-called hemolysis, i.e. the destruction of red blood cells, occurred as a result of improper blood transfusion,” Soroush said.
“As a result, only a red liquid was injected to the patient and it did not have the necessary efficiency, but when this device is used, the pressure can be adjusted up to one millimeter of mercury and the blood is transferred correctly,” Soroush said.
Pressure infusion bag is a product that adapts air pressure to speed up the infusion speed and liquid volume during blood transfusion.
In a relevant development in February, the deputy head of Iran’s Blood Transfusion Organization for technological affairs announced that nucleic acid testing (NAT) screening test was being performed in the country to detect viral diseases like hepatitis B, hepatitis C, and AIDS in blood donation samples.
“One of the new technologies of the Blood Transfusion Organization is the NAT screening test, which is a molecular test for detecting viral diseases like hepatitis B, hepatitis C, and AIDS. Early detection of viral diseases and contamination in the blood increases blood safety and shortens the time it takes for the virus to enter the laboratory,” Abdollah Salek Moqaddam told ANA.
He added that at present, the NAT test is being conducted only in Tehran, and it will be performed in other parts of the country in two months.
Salek Moqaddam also said that antibody screening in donated blood is being performed in developed countries of the world, adding, “Fortunately, devices related to this technology have been provided to all provinces of the country, and this screening test will be operational in the next few days.”
NAT is a molecular technique for screening blood donations to reduce the risk of transfusion transmitted infections (TTIs) in the recipients, thus providing an additional layer of blood safety.
4155/v
